Physician
United Providers of Health
United Providers of Health was paid $425K by Medicaid between Nov 2022 and Apr 2024, across 10 billing codes. Its largest line is 87637, Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV — 44% of everything it billed.
33Billing provider infoUNITED PROVIDERS OF HEALTH
BETHEL, NC 27812
BETHEL, NC 27812
33aNPI1518697341assigned 06/14/2022
33bProvider typeInternal Medicine Physician
28Total paid$425K
24GClaims15,212
24DCodes billed10
24AFirst – last monthNov 2022 – Apr 2024
Compared with peers
Next to other Internal Medicine Physician providers in North Carolina
Rank by total paid#154 of 616
Median peer was paid$74K
This provider vs. median5.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 36 | $966.11 | |
| 2023 | 7,183 | $195K | |
| 2024incomplete | 7,993 | $229K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 44% | 2,807 | 1,167 | $187K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 22% | 3,668 | 1,561 | $93K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 12% | 3,670 | 1,563 | $52K |
| 87581 | 11% | 3,682 | 1,562 | $49K | |
| 87631 | 7.8% | 857 | 396 | $33K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 181 | 99 | $5K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 107 | 60 | $4K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 125 | 72 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 97 | 55 | $1K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 18 | 12 | $616.56 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMAYO, CAROLYN (MANAGING PARTNER)